End Points for Clinical Trials in Acute Heart Failure Syndromes

This publication has 49 references indexed in Scilit:

• Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)
  American Heart Journal, 2009
• Cardiorenal Syndrome
  Journal of the American College of Cardiology, 2008
• The PROTECT Pilot Study: A Randomized, Placebo-Controlled, Dose-Finding Study of the Adenosine A1 Receptor Antagonist Rolofylline in Patients With Acute Heart Failure and Renal Impairment
  Journal of Cardiac Failure, 2008
• Improvements in Signs and Symptoms During Hospitalization for Acute Heart Failure Follow Different Patterns and Depend on the Measurement Scales Used: An International, Prospective Registry to Evaluate the Evolution of Measures of Disease Severity in Acute Heart Failure (MEASURE-AHF)
  Journal of Cardiac Failure, 2008
• A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach
  European Heart Journal, 2008
• Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart FailureClassification and Regression Tree Analysis
  JAMA, 2005
• Users' Guides to the Medical Literature
  JAMA, 1999
• Surrogate endpoints in clinical trials: Definition and operational criteria
  Statistics in Medicine, 1989
• Comparison of Clinical Dyspnea Ratings and Psychophysical Measurements of Respiratory Sensation in Obstructive Airway Disease^1–4
  American Review of Respiratory Disease, 1987
• The Measurement of Dyspnea
  Chest, 1984